Figure 2. 58-year-old woman after resection of the pancreatic tail because of a carcinoid tumour 3 years previously. The patient received Iomeprol 400: (a, b) arterial phase, (c, d) portal venous phase. 51-year-old man after Whipple procedure, who received Iomeprol 300: arterial phase (e, f), portal venous phase (g, h). Figures 2a–d show the higher arterial and portal venous phase contrast enhancement of the pancreatic head and body with Iomeprol 400 compared with the pancreatic body and tail of the patient in Figures 2e–h who had received Iomeprol 300. Additionally, the higher arterial phase contrast enhancement of the large and small arteries, the kidneys and the small intestine and the higher portal venous contrast enhancement of the portal vein and the small intestine with Iomeprol 400 (a–d) compared with Iomeprol 300 (e–h) are demonstrated.